FOCUSED ON DEVELOPMENT OF ADVANCED SOLUTIONS FOR REGENERATIVE SURGICAL PATCHES AND ADHESIVES

PRODUCT TIMELINE

Nurami’s preliminary product is ArtiFascia®, a highly effective surgical patch with integrated temperature sensitive sealant. ArtiFascia® is in the clinical stage and will be market ready in 2023. Our pipeline incudes ArtiFixTM, a soft tissue sealant patch, which does not require suturing and NovaFibreXTM, a groundbreaking surgical adhesive for general surgery, which will withstand premature degradation while adhering effectively to the wet environment of internal organs.

Product

Surgery
Type

Device
Development

Preclinical
Studies

Pilot Clinical
Trials

Pivotal Clinical
Trials

Regulatory
Clearance

Commercialization

Neurosurgery

FDA and
CE in 2022

2023

Neuro &
general surgery

2023

General
surgery

Product

Surgery
Type

Device
Development

Preclinical
Studies

Pilot Clinical
Trials

Pivotal Clinical
Trials

Regulatory
Clearance

Commercialization

Neurosurgery

FDA and
CE in 2022

2023

Neuro &
general surgery

2023

General
surgery

Surgery
Type

Neurosurgery

Neuro &
general surgery

General
surgery

Device
Development

Preclinical
Studies

Pilot Clinical Trials

2023

Pivot Clinical Trials

Regulatory
Clearance

FDA and
CE in 2022

Commercialization

2023

Commerci-
alization

2022